1. The beta-agonist controversy;Taylor, D.R.; Sears, M.R.; Cockcroft, D.W.;Med Clin North Am; lung diseases Part II: Asthma, sleep, occupational exposures and AIDS,1996
2. A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine;Ahrens, R.C.; Bonham, A.C.; Maxwell, G.A.; Weinberger, M.W.;Am Rev Respir Dis,1984
3. Tolerance to beta-agonists;Tattersfield, A.E.;Bull Eur Physiopathol Respir,1985
4. Tolerance to the nonbronchodilator effects ofinhaled 02-agonists in asthma;O'Connor, B.J.; Aikman, S.L.; Barnes, P.J.;N EnglJ Med,1992
5. Airway hyperresponsiveness: definition, measurement, and clinical relevance;Cockcroft, D.W.; Hargreave, F.E.,1991